A remarkably rapid CuAAC strategy afforded benzoxepine-1,2,3-triazole hybrids as potential antibacterial/cytotoxic agents.
No takes yet. Share an insight, caveat, or question.
Kuntala et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: